CRC
is a leading healthcare consultancy in the economic
analysis and understanding of medical treatment and
development.
Our expertise in health economics, disease modelling and
statistical analysis compliments our unique health
outcomes research database (HOD@R) to determine a wide
spectrum of welfare related issues such as quality of
life, cost/benefit analysis of treatment and health
utility.
CRC provides:
Quantifiable
benefits of medical treatment in terms of $$ and
utility
Patient data on more
than 50,000 patients gathered from one of the largest
health trust providers in the UK, encompassing linked
health utility data, Primary and Secondary care
information
4th hurdle
acceptance of economic indices for reimbursement
approval and business casing (e.g. NICE, FDA)
Rapid access to
specific and segmented user group data
Comparative
treatment economic analysis
Access to a rich and
unique population database
Advanced modelling
skills, trend analysis and evolution of market
requirements
Health
Utilities Inc.
HUI®
for
Utilities PROs QALYs CEA/CUA
and more…
Provides community
preference-based, single summary utility scores as
recommended by the US Panel, NICE, CCOHTA, CDHA and other
national organizations.
A generic system for patient reported outcomes (PROs)
integrating morbidity and mortality effects of HRQL for
calculating QALYs and HALE.
Available for face-to-face or telephone interviewer
administration, as well as mail-out or take-home for
self-completion in Self- and Proxy-assessment versions.
Many language versions available.
Used in 100s of studies world-wide since 1992.
NEW!a
Web-Based System for
administering the HUI, monitoring surveys and analysing
HUI data in real time.
THE JOURNAL
OF APPLIED RESEARCH
In
CLINICAL AND EXPERIMENTAL THERAPEUTICS
The Journal of Applied Research in Clinical and Experimental
Therapeutics is a peer reviewed, rapid publication, quarterly
Journal. Its’ mission is to promote excellence in the clinical
practice of medicine by disseminating fundamental treatment
knowledge, in all legitimate specialties, gained from
prospective and retrospective research.
•
Submitted articles will be reviewed within 15 days
• Accepted articles are published within 120 days
For all
additional information, please consult our website at www.jarcet.com, or James
H. Jenkins at jhjjar@aol.com.
Outcome Technologies
is a dedicated outcome services provider supplying software,
services, and data for outcomes research and health economics.
Formed by doctors to meet the increasing needs of managing outcome
data in the clinical environment, Outcome Technologies prides
itself on meeting and understanding both the clinical and technical
issues of rapidly deploying and evolving an outcomes study to fulfil
business need.
Located in London and operating globally, Outcome Technologies
systems are used by a variety of outcomes stakeholders including
pharmaceutical and medical device companies, clinician groups and
government agencies. Outcome Technologies is backed by BUPA,
a leading international health and care group caring for 7.2 million
people globally with a turnover in excess of $7 billion.
Providing multi-disciplinary approaches and effective
solutions in outcomes research and health economics
from our offices in Oxford and Vancouver.
Patient-Reported Outcomes Research
Health Economics
Epidemiology
Translation and Cultural Adaptation
Training Workshops
Professional opportunities with Oxford Outcomes We are currently recruiting senior health economists
and senior outcomes
researchers for both our Oxford and Vancouver offices.
See our website for information.
ISPOR
10 Year Exhibitor
